Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Parenteral Drugs Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Parenteral Drugs Market Status and Forecast (2016-2027)
      • 1.3.2 Global Parenteral Drugs Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Parenteral Drugs Supply by Company

    • 2.1 Global Parenteral Drugs Sales Volume by Company
    • 2.2 Global Parenteral Drugs Sales Value by Company
    • 2.3 Global Parenteral Drugs Price by Company
    • 2.4 Parenteral Drugs Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Parenteral Drugs Market Status by Category

    • 3.1 Parenteral Drugs Category Introduction
      • 3.1.1 LVP Drug
      • 3.1.2 SVP Drug
    • 3.2 Global Parenteral Drugs Market by Category
      • 3.2.1 Global Parenteral Drugs Sales Volume by Category (2016-2021)
      • 3.2.2 Global Parenteral Drugs Sales Value by Category (2016-2021)
      • 3.2.3 Global Parenteral Drugs Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Parenteral Drugs Market Status by End User/Segment

    • 4.1 Parenteral Drugs Segment by End User/Segment
      • 4.1.1 Hospitals
      • 4.1.2 Medical Centers
      • 4.1.3 Others
    • 4.2 Global Parenteral Drugs Market by End User/Segment
      • 4.2.1 Global Parenteral Drugs Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Parenteral Drugs Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Parenteral Drugs Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Parenteral Drugs Market Status by Region

    • 5.1 Global Parenteral Drugs Market by Region
      • 5.1.1 Global Parenteral Drugs Sales Volume by Region
      • 5.1.2 Global Parenteral Drugs Sales Value by Region
    • 5.2 North America Parenteral Drugs Market Status
    • 5.3 Europe Parenteral Drugs Market Status
    • 5.4 Asia Pacific Parenteral Drugs Market Status
    • 5.5 Central & South America Parenteral Drugs Market Status
    • 5.6 Middle East & Africa Parenteral Drugs Market Status

    6 North America Parenteral Drugs Market Status

    • 6.1 North America Parenteral Drugs Market by Country
      • 6.1.1 North America Parenteral Drugs Sales Volume by Country (2016-2021)
      • 6.1.2 North America Parenteral Drugs Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Parenteral Drugs Market Status

    • 7.1 Europe Parenteral Drugs Market by Country
      • 7.1.1 Europe Parenteral Drugs Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Parenteral Drugs Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Parenteral Drugs Market Status

    • 8.1 Asia Pacific Parenteral Drugs Market by Country
      • 8.1.1 Asia Pacific Parenteral Drugs Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Parenteral Drugs Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Parenteral Drugs Market Status

    • 9.1 Central & South America Parenteral Drugs Market by Country
      • 9.1.1 Central & South America Parenteral Drugs Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Parenteral Drugs Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Parenteral Drugs Market Status

    • 10.1 Middle East & Africa Parenteral Drugs Market by Country
      • 10.1.1 Middle East & Africa Parenteral Drugs Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Parenteral Drugs Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Parenteral Drugs Manufacturing Cost Analysis
    • 11.5 Parenteral Drugs Sales Channel and Distributors Analysis
      • 11.5.1 Parenteral Drugs Sales Channel
      • 11.5.2 Parenteral Drugs Distributors
    • 11.6 Parenteral Drugs Downstream Major Buyers

    12 Global Parenteral Drugs Market Forecast by Category and by End User/Segment

    • 12.1 Global Parenteral Drugs Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Parenteral Drugs Forecast by Category
      • 12.2.1 Global Parenteral Drugs Sales Volume Forecast by Category
      • 12.2.2 Global Parenteral Drugs Sales Value Forecast by Category
      • 12.2.3 Global Parenteral Drugs Price Forecast by Category
    • 12.3 Global Parenteral Drugs Forecast by End User/Segment
      • 12.3.1 Global Parenteral Drugs Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Parenteral Drugs Sales Value Forecast by End User/Segment
      • 12.3.3 Global Parenteral Drugs Price Forecast by End User/Segment

    13 Global Parenteral Drugs Market Forecast by Region/Country

    • 13.1 Global Parenteral Drugs Market Forecast by Region (2022-2027)
      • 13.1.1 Global Parenteral Drugs Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Parenteral Drugs Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Wintac Limited
      • 14.1.1 Company Information
      • 14.1.2 Parenteral Drugs Product Introduction
      • 14.1.3 Wintac Limited Parenteral Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Teva Pharmaceutical Industries
      • 14.2.1 Company Information
      • 14.2.2 Parenteral Drugs Product Introduction
      • 14.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Southwest Pharmaceutical
      • 14.3.1 Company Information
      • 14.3.2 Parenteral Drugs Product Introduction
      • 14.3.3 Southwest Pharmaceutical Parenteral Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 PSI Ltd
      • 14.4.1 Company Information
      • 14.4.2 Parenteral Drugs Product Introduction
      • 14.4.3 PSI Ltd Parenteral Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Pisa
      • 14.5.1 Company Information
      • 14.5.2 Parenteral Drugs Product Introduction
      • 14.5.3 Pisa Parenteral Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Pfizer (Hospira)
      • 14.6.1 Company Information
      • 14.6.2 Parenteral Drugs Product Introduction
      • 14.6.3 Pfizer (Hospira) Parenteral Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Patheon
      • 14.7.1 Company Information
      • 14.7.2 Parenteral Drugs Product Introduction
      • 14.7.3 Patheon Parenteral Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Ozon Pharmaceuticals Ltd
      • 14.8.1 Company Information
      • 14.8.2 Parenteral Drugs Product Introduction
      • 14.8.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Ostuka Pharmaceutical
      • 14.9.1 Company Information
      • 14.9.2 Parenteral Drugs Product Introduction
      • 14.9.3 Ostuka Pharmaceutical Parenteral Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Kelun Pharma
      • 14.10.1 Company Information
      • 14.10.2 Parenteral Drugs Product Introduction
      • 14.10.3 Kelun Pharma Parenteral Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Fresenius
    • 14.12 Cook Pharmica
    • 14.13 BML Parenteral Drugs
    • 14.14 Beximco Pharma
    • 14.15 Baxter Healthcare Corporation
    • 14.16 BAG Healthcare
    • 14.17 B. Braun
    • 14.18 AXA Parenterals Ltd
    • 14.19 Aspen Holdings
    • 14.20 Albert David
    • 14.21 Acebright
    • 14.22 Abbott

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Parenteral Drugs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Parenteral Drugs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      LVP Drug
      SVP Drug

      Segmented by End User/Segment
      Hospitals
      Medical Centers
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Wintac Limited
      Teva Pharmaceutical Industries
      Southwest Pharmaceutical
      PSI Ltd
      Pisa
      Pfizer (Hospira)
      Patheon
      Ozon Pharmaceuticals Ltd
      Ostuka Pharmaceutical
      Kelun Pharma
      Fresenius
      Cook Pharmica
      BML Parenteral Drugs
      Beximco Pharma
      Baxter Healthcare Corporation
      BAG Healthcare
      B. Braun
      AXA Parenterals Ltd
      Aspen Holdings
      Albert David
      Acebright
      Abbott
      Buy now